The team — led by David F. Meaney, PhD, and Douglas H. Smith, MD, of the University of Pennsylvania in Philadelphia — will investigate how a concussion influences many aspects of the brain, including neural circuit connectivity, multiple cell types and blood flow.
The researchers will use the Paul G. Allen Family Foundation grant to capture cell, circuit, blood flow and metabolism level data to understand how the brain responds during and after concussion. Paul Allen and his sister Jody Allen founded the Paul G. Allen Family Foundation in 1988. Mr. Allen, who serves as chairman of the foundation’s board, co-founded Microsoft in 1975.
The project’s goal is to discover new clinical interventions to improve traumatic brain injury prevention and recovery.
“We have assembled a diverse team of experts in many fields across several academic institutions to take a comprehensive approach to the problem, and are very grateful for the Paul G. Allen Family Foundation’s bold vision to accelerate concussion science and treatment,” Dr. Meaney said.
More articles on health IT:
VA’s most expensive task? Modernizing IT, says Shulkin
IBM: 5 insights on Watson’s oncology performance
Medicare would save $63M annually with HIEs, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
